期刊文献+

应激性高血糖与急性心肌梗死并发心律失常相关性探讨 被引量:6

下载PDF
导出
摘要 目的探讨急性心肌梗死时应激性高血糖与心律失常的关系。方法对86例既往无糖尿病病史的急性心肌梗死患者入院后次日测空腹血糖分组,分为血糖正常组(空腹血糖≤6.1mmol/L)和血糖增高组(>6.1mmol/L),并持续进行心电监护,比较两组之间心律失常发生率。结果血糖增高组的急性心肌梗死患者心律失常的发生率明显高于血糖正常组(P<0.01)。结论应激性血糖升高的急性心肌梗死患者心律失常的发生率明显增高,预后差。
作者 焦云丽
出处 《中国现代医生》 2010年第3期146-147,共2页 China Modern Doctor
  • 相关文献

参考文献5

  • 1王旭,马树沛,王晏平,纪霞.急性心肌梗塞内分泌代谢改变对糖代谢的影响及其临床意义[J].临床心血管病杂志,1994,10(5):272-275. 被引量:30
  • 2Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrythmias[J]. Lancet, 1994,343(8890) : 155-158.
  • 3Ceriello A. Insulin, glycemic control, and C-reactive protein during myocardial infarction[J]. Diabetes Care,2004,27(12) :3017-3018.
  • 4Dandona P,Aljada A, Bandyopanhyay A. The potential therapeutic role of insulin in acute myocardial infarction in patients admitted to intensive care and in those with unspeeitied hyperglycemia[J]. Diabetes Care, 2003, 26(2):516-519.
  • 5Garg R, Chaudhuri A, Munschauer F, et al. Hyperglycemia,insulin, and acute ischemic stroke:a mechanistic justification for a trial of insulin infusion therapy[J]. Stroke, 2006,37( 1 ) : 267-273.

共引文献29

同被引文献58

  • 1陈愉安,余红.胺碘酮加镁极化液治疗充血性心力衰竭合并室性心律失常疗效观察[J].中国医药导报,2006,3(33):78-79. 被引量:1
  • 2王国敏,莫淑琴.急诊应用胺碘酮治疗冠心病快速心律失常的临床疗效[J].中国老年学杂志,2014,34(9):2539-2541. 被引量:84
  • 3段连强,王廷选.应激性高血糖与急性心肌梗死相关因素分析[J].中外健康文摘,2009.40(6):605-606.
  • 4Deedwania P,Kosiborod M,Barrett E. Hyperglycemia and acute coronary syndrome:a scientific statement from the American heart as sociation diabetes commit ee of the council on nutrition,physical activity,and metabolism[J].{H}CIRCULATION,2008.1610-1619.
  • 5Sozański T,Kucharska AZ,Szumny A,et al.The protective effect of the Cornus mas fruits(cornelian cherry)on hypertriglyceridemia andatherosclerosis through PPARαactivation in hypercholesterolemic rabbits[J].Phytomedicine,2014,21(13):1774-1784.
  • 6Krysiak R,Zmuda W,OkopieńB.The effect of shortterm simvastatin treatment on plasma adipokine levels in patients with isolated hypercholesterolemia:A preliminary report[J].Pharmacol Rep,2014,66(5):880-884.
  • 7Ramsey LB,Johnson SG,Caudle KE,et al.The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy:2014update[J].Clin Pharmacol Ther,2014,96(4):423-428.
  • 8Mangili OC,Moron Gagliardi AC,Mangili LC,et al.Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects[J].Atherosclerosis,2014,233(1):319-325.
  • 9Hamoud S,Hayek T,Volkova N,et al.Pomegranate extract(POMx)decreases the atherogenicity of serum and of human monocyte-derived macrophages(HMDM)in simvastatin-treated hypercholesterolemic patients:a double-blinded,placebo-controlled,randomized,prospective pilot study[J].Atherosclerosis,2014,232(1):204-210.
  • 10Ballantyne CM,Hoogeveen RC,Raya JL,et al.Efficacy,safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20mg plus ezetimibe 10mg vs.simvastatin 40 or 80mg plus ezetimibe10mg in high-risk patients:Results of the GRAVITY randomized study[J].Atherosclerosis,2014,232(1):86-93.

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部